Development and Pilot Evaluation of an Artificial Intelligence-Assisted System for Automated Oxygen Flow Regulation: The Saturista Device
Sponsor: Koç University
Trial Details
| Condition | Oxygen Therapy |
| Status | Active |
| Participants | 7 |
| Est. Completion | 1 June 2026 |
| Last Updated | 8 May 2026 |
Primary Outcome
Real-Time Data Display Performance
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Healthy adult volunteers aged 18 years or older * Resting oxygen saturation (SpO₂) within the normal range at baseline * Ability to understand the study procedures and provide written informed consent * Willingness to participate in all planned testing scenarios Exclusion Criteria: * History of chronic respiratory disease, including asthma, chronic obstructive pulmonary disease, or interstitial lung disease * Known cardiovascular disease or any condition that may affect oxygen saturation or hemodynamic stability * Current respiratory symptoms, acute infection, or fever at the time of participation * Anemia, peripheral circulatory disorders, or any condition that may interfere with pulse oximetry measurements * Skin lesions, deformity, or injury at the intended probe placement site * Pregnancy * History of syncope, intolerance to short-duration breath-holding, or any condition that may increase risk during testing * Inability or unwillingness to comply with study procedures
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service